CLINICAL_TRIALS
trial_result
· 2015-12-30
Clinical Trial Update: A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension [Phase 2]
Summary
A Phase 2 dose-response study of UT-15C SR in patients with exercise-induced pulmonary hypertension; results from the trial have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Therapeutics | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2015-12-30